MAX REINHARDT - 04 Jun 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
President, Rest of World
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
04 Jun 2021
Net transactions value
-$212,406
Form type
4
Filing time
08 Jun 2021, 16:16:39 UTC
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $74,587 -1,222 -8.7% $61.04 12,778 04 Jun 2021 Direct F1
transaction PCRX Common Stock Sale $137,819 -2,278 -18% $60.50 10,500 07 Jun 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
F2 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.